• Webinars
  • Cardio-Metabolic and Renal Diseases, MASH (NASH)
  • 27-06-2024

Webinar – Clinical consequences of the New MASLD Nomenclature

On the 27th of June, we organized the webinar: 'Clinical Consequences of the New MASLD Nomenclature' with guest speaker Prof. Maja Thiele.During this webinar, our speaker and hosts dived into the following topics:Is the MASLD nomeclature...

  • Webinars
  • Cardio-Metabolic and Renal Diseases, MASH (NASH)

Webinar: Lifestyle Interventions in NAFLD/NASH

On the 19th of September, we presented the 9th webinar of our NASH Webinar Series. During this webinar, speaker Professor Zelber-Sagi explored the relationship between diet and NAFLD, emphasizing that diet not only causes NAFLD but can also serve ...

  • Webinars
  • Cardio-Metabolic and Renal Diseases, MASH (NASH)

NAFLD: patient identification strategies

In this webinar, Prof. Jörn Schattenberg discussed his paper in Nature Reviews Gastroenterology & Hepatology on effective and efficient models of care for patients with NAFLD. Standardized patient care pathways for NAFLD are not yet widely im...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.
  • Webinars
  • Cardio-Metabolic and Renal Diseases, MASH (NASH)

Public health and policy responses to NAFLD/NASH

Topics that has been discussed:The Impact of NAFLD/NASH What is being done to tackle NAFLD/NASH globally and nationally What still needs to be done in the fight against NAFLD/NASH How can you/your country advance the battle against ...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.
  • Webinars
  • Cardio-Metabolic and Renal Diseases, MASH (NASH)

Genetic architecture of NAFLD: where do we stand?

Genome-wide association studies have uncovered robust and reproducible associations between several genetic variations and the natural history of NAFLD. During this webinar, Professor Eric Trépo reviewed these findings that have provided compelli...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.
  • Webinars
  • Cardio-Metabolic and Renal Diseases, MASH (NASH)

Promising phase 2B trial results of Lanifibranor in NASH

During this webinar Prof. Sven Francque discussed the phase 2 trial results of the Pan-PPAR Agonist Lanifibranor in nonalcoholic steatohepatitis (NASH) patients. Currently there is an unmet need of management of NASH. Lanifibranor is a pan-PPAR (p...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.
  • Webinars
  • Cardio-Metabolic and Renal Diseases, MASH (NASH)

Insulin Resistance in NAFLD

This webinar focussed on the close multilevel links between insulin resistance/T2DM and NAFLD.Topics that are discussed:Epidemiological links between NAFLD, insulin resistance and T2DM Insulin resistance as root cause of NAFLD: mechan...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.

Download

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Request for proposal

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn